Why diversity within clinical trials matters in Birmingham


A local expert weighs in on the impact of clinical trial diversity in the Magic City in light of new FDA guidelines.

Previous International audience hails UPMC's new vision and rehab complex
Next HCA Healthcare names new West Florida Division president